M&A Deal Summary

Verb Biotics Acquires YSOPIA Bioscience - Health & Wellness Strains

On June 13, 2023, Verb Biotics acquired life science company YSOPIA Bioscience - Health & Wellness Strains from YSOPIA Bioscience

Acquisition Highlights
  • This is Verb Biotics’ 1st transaction in the Life Science sector.
  • This is Verb Biotics’ 1st transaction in France.

M&A Deal Summary

Date 2023-06-13
Target YSOPIA Bioscience - Health & Wellness Strains
Sector Life Science
Buyer(s) Verb Biotics
Sellers(s) YSOPIA Bioscience
Deal Type Divestiture

Target

YSOPIA Bioscience - Health & Wellness Strains

Bordeaux, France
YSOPIA Bioscience's Health & Wellness Strains portfolio includes well-characterized libraries of Christensenella minuta available, the associated IP, and other unique bacterial strains.

Search 214,239 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Verb Biotics

Boston, Massachusetts, United States

Category Company
Founded 2021
Sector Life Science
DESCRIPTION

Verb Biotics a microbiome innovation company that applies science, technology, and intentional development to deliver microbiome health solutions. Verb Biotics is a business-to-business ingredient supplier of pro, post and synbiotics for food, beverage and dietary supplement brands. Verb Biotics was founded in 2021 and is based in Boston, Massachusetts.


DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Divestiture M&A Deals 1 of 1
Country: France M&A 1 of 1
Year: 2023 M&A 1 of 1

Seller(S) 1

SELLER

YSOPIA Bioscience

Bordeaux, France

Category Company
Founded 2010
Sector Life Science
DESCRIPTION

YSOPIA Bioscience is a clinical-stage biotech leading next-generation microbiome-based living biotherapies. YSOPIA Bioscience was founded in 2010 and is based in Bordeaux, France.


DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Divestiture M&A Deals 1 of 1
Country: France M&A 1 of 1
Year: 2023 M&A 1 of 1